$ANEB 4 SEC Filings

Filed On	Filing
07 Apr 2025	Form 4: Lawler Joseph F., Director Granted 38,236 Stock Option (right to buy)
07 Apr 2025	Form 4: Shah Bimal R., Director Granted 31,618 Stock Option (right to buy)
07 Apr 2025	Form 4: Cundy Kenneth C, Chief Scientific Officer Granted 115,037 Stock Option (right to buy)
07 Apr 2025	Form 4: Aryeh Jason, Director Granted 29,964 Stock Option (right to buy)
07 Apr 2025	Form 4: Cunningham, Richard Anthony, Director Granted 316,352 Stock Option (right to buy)
07 Apr 2025	Form 4: Lin Kenneth, Director Granted 29,964 Stock Option (right to buy)
07 Apr 2025	Form 4: English Aron R., Director Granted 27,647 Stock Option (right to buy)
07 Apr 2025	Form 4: Calloway Nathaniel, Director Granted 28,309 Stock Option (right to buy)
07 Apr 2025	Form 4: Kupchyk Areta, Director Granted 27,647 Stock Option (right to buy)
26 Dec 2024	Form 4: English Aron R., Director and 1 other Bought 10,101,010 shares ($10M)
10 Dec 2024	Form 4: Cunningham, Richard Anthony, Director Granted 254,433 Stock Option (right to buy)
17 Jun 2024	Form 4: Lin Kenneth, Director Granted 44,149 Stock Option (right to buy)
17 Jun 2024	Form 4: Calloway Nathaniel, Director Granted 43,322 Stock Option (right to buy)
17 Jun 2024	Form 4: Kupchyk Areta, Director Granted 42,991 Stock Option (right to buy)
17 Jun 2024	Form 4: Lawler Joseph F., Director Granted 48,285 Stock Option (right to buy)
17 Jun 2024	Form 4: Shah Bimal R., Director Granted 44,976 Stock Option (right to buy)
17 Jun 2024	Form 4: English Aron R., Director Granted 42,991 Stock Option (right to buy)
17 Jun 2024	Form 4: Aryeh Jason, Director Granted 44,149 Stock Option (right to buy)
01 Mar 2024	Form 4: Cundy Kenneth C, Chief Scientific Officer Granted 72,613 Stock Option (right to buy)
20 Dec 2023	Form 4: English Aron R., Director and 2 others Received 300,000 shares as a grant or award · Gave 300,000 shares as a gift · Acquired 300,000 shares (Gift)

Comments